华兰股份 (301093)

Jiangsu Hualan New Pharmaceutical Material Co., Ltd.

ASZ

Tags

CSI Share Buyback IndexArtificial Intelligence (AI)Insurance Heavy PositionsVenture Capital ConceptInnovative DrugsPharmaceutical ManufacturingBuyback PlansPlanned Increase of HoldingsMargin Trading and Securities LendingBonus Share Potential

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 16420.16
  • Circulating A-Shares(W): 15693.40
  • Earnings Per Share(RMB): 0.3250
  • Net Assets Per Share(RMB): 13.2387
  • Operating Revenue(W RMB): 44124.47
  • Total Profit(W RMB): 6200.91
  • Net Profit Attributable to Parent(W RMB): 5331.60
  • Net Profit Growth Rate(%): 2.06
  • Weighted Return on Equity(%): 2.3700
  • Operating Cash Flow Per Share(RMB): 0.4650
  • Undistributed Profit Per Share(RMB): 2.7522
  • Capital Reserve Per Share(RMB): 9.6821

2. Main Business

The main business covers:

  • Research, production, and sales of packaging materials that are in direct contact with injectable drugs.

3. Company Basic Information

  • Company Name: Jiangsu Hualan New Pharmaceutical Material Co., Ltd.
  • Listing Date: 2021-11-01
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 1488 Cheng Road, Shengang Town, Lingang New City, Jiangyin City, Jiangsu Province, China.
  • Website: www.hua-lan.com
  • Company Profile: According to the audit report issued by Lixin Certified Public Accountants Co., Ltd. on September 15, 2009, as of August 31, 2009, Lanling Bottle Stopper's audited total assets were 56,134.92 million yuan, total liabilities were 43,729.13 million yuan, and total net assets were 12,405.79 million yuan. According to the evaluation report issued by Jiangsu Lixin Yonghua Asset Appraisal & Real Estate Appraisal Co., Ltd. on September 18, 2009, as of August 31, 2009, Lanling Bottle Stopper's evaluated total assets were 59,423.82 million yuan, total liabilities were 43,729.13 million yuan, and total net assets were 15,694.69 million yuan. On October 9, 2009, Lanling Bottle Stopper held a temporary shareholders' meeting and resolved to change the company type from a limited company to a joint-stock company. It was voted to convert 88,000,000 yuan out of the total audited net assets of 12,405.79 million yuan as of August 31, 2009 into the company's paid-in capital of 88,000,000 shares, with a par value of 1 yuan per share, and the remaining 3,605.79 million yuan was included in the company's capital reserve. On October 10, 2009, Lixin Certified Public Accountants Co., Ltd. issued the "Capital Verification Report" verifying that as of October 9, 2009, Hualan Co., Ltd. (in preparation) had, in accordance with the relevant provisions of the Company Law and the company's share conversion plan, converted the total audited owner's equity (net assets) of Lanling Bottle Stopper as of August 31, 2009, amounting to 12,405.79 million yuan, into a total of 88,000,000 shares at a ratio of 1:0.709346, with 1 yuan per share, totaling share capital of 88,000,000 yuan. The amount exceeding the share capital, 3,605.79 million yuan, was included in the capital reserve. All promoters' capital contributions were in place. On October 16, 2009, the Wuxi Administration for Industry and Commerce issued the "Business License for Enterprise Legal Person". Unified Social Credit Code: 913202006079820552.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Jiangyin Hualan Mechanical & Electrical Technology Co., Ltd. General Legal Person 3676.40 23.43
2 Rui Zhong Life Insurance Co., Ltd. - Own Funds Insurance 2690.16 17.14
3 Beijing Fuyuan Investment Management Co., Ltd. - Fuyuan Fuxing No.1 Private Securities Investment Fund Private Securities Investment Fund 411.18 2.62
4 Jiangyin Hualan Investment Co., Ltd. General Legal Person 210.81 1.34
5 Jiangyin Huajuying Investment Enterprise (Limited Partnership) General Legal Person 104.00 0.66
6 Galaxy Kangle Equity Securities Investment Fund Class A Fund 22.55 0.14
7 ChinaAMC SSE Composite Total Return Index Enhanced Securities Investment Fund Class A Fund 2.09 0.01

5. Concept Sectors

  • Venture Capital
  • Artificial Intelligence
  • Innovative Drugs
  • Margin Trading & Securities Lending
  • Insurance Heavy Holdings
  • Bonus & Share Split Potential
  • Share Repurchase Plan
  • Proposed Shareholding Increase
  • Commitment Not to Reduce Holdings
  • CSI Share Repurchase Index

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information